Michael Powell

Develops and markets catalytic biopharmaceutical products

Operates as a biopharmaceutical company which focuses on the treatment of obesity

Develops and commercializes therapeutics for inflammatory diseases

The AIDS Vaccine Advocacy Coalition (AVAC) is an international nonprofit organization committed to accelerating the ethical development and equitable delivery of effective HIV prevention options to achieve health equity. The non-profit company is based in New York, NY. AVAC operates independently without pharmaceutical industry funding and collaborates with partners to advocate for funding, research, and implementation efforts aimed at ending HIV and preparing for future pandemics. The organization’s work includes a broad range of HIV prevention strategies such as vaccines, pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), microbicides, condoms, treatment, and combination prevention tailored to community needs. AVAC focuses on multipurpose prevention technologies that address multiple sexual and reproductive health needs, and emphasizes community-centered, gender-responsive approaches, good participatory practices, and health equity, particularly in lower- and middle-income countries. The organization supports advocacy, education, policy development, and knowledge exchange, providing resources and tracking scientific and policy developments for stakeholders worldwide. The company was founded by Chris Collins.

Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy

Provides biotechnology services

Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements.

Develops pharmaceutical drugs for pain management

Provides pharmaceutical products

Manufactures pharmaceuticals products

Functions as a College/University

Functions as a College/University

Functions as a College/University

Develops drug therapeutics

Discovers and develops medicines for cancer

Engages in the acquisition, exploration, development, and mining of gold, silver, and other precious and base metal properties

Engages in research and development of pharmaceutical products

Develops therapeutics for gastrointestinal and liver diseases

Develops antibacterial drugs for the treatment of infections

Develops and manufactures small molecule drugs for the treatment of cancer

Develops therapeutic vaccines for cancer and infectious diseases

Engages in the development of micro ribonucleic acid based oncology therapeutics

Omega Fund Management invests in private and public companies located in the US and Europe. The firm focuses on sectors such as biotechnology, life sciences, healthcare and medical devices. It provides financing for seed, early, mid and later stage capital requirements. It makes direct secondary investments along with follow-on investments.

Operates as a biopharmaceutical company

Manufactures pharmaceutical products

Develops specialty drugs

Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics

Operates as a clinical stage biopharmaceutical company

Manufactures and sells pharmaceutical preparations

Develops antibody-based Immuno-oncology therapeutics

Operates as a clinical-stage biopharmaceutical company that develops small molecules

Operates as a shell company

Functions as a College/University

Develops allosteric inhibitors for RAS-driven cancers

Manufactures medicines that modulates innate immune system to fight cancer

Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors

Engages in discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats